The burden of cardiovascular diseases in Asia from 1990 to 2023: an analysis for the Global Burden of Disease Study study 2023
Although age-standardized CVD mortality and DALYs have declined across Asia, the overall burden remains substantial and heterogeneous, and region-specific strategies targeting dominant risk factors are essential to effectively reduce CVD burden across diverse Asian populations.